Dextran derivatives endowed, particularly with anti-coagulant properties and anti-complementary properties, their preparation and their biological uses
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 26, 1988
Grant Date -
N/A
app pub date -
Nov 30, 1984
filing date -
Nov 30, 1983
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The dextran derivatives have a molecular weight higher than about 5000 daltons and comprise statistically at least about 35% of units substituted by radicals having a COO.sup.- function and at least 3% of units comprising a group of structure ##STR1## wherein R.sub.1 is a single bond; or a ##STR2## group, R.sub.2 is an anion of an inorganic or an organic salt and n is a number from 1 to 4.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully